ABSTRACT The high global burden of cryptococcosis has made development of a protective vaccine a public health priority. We previously demonstrated that a vaccine composed of recombinant Cryptococcus neoformans chitin deacetylase 2 (Cda2) delivered in glucan particles (GPs) protects BALB/c and C57BL/6 mice from an otherwise lethal challenge with a highly virulent C. neoformans strain. https://www.roneverhart.com/Asus-ROG-Zephyrus-GU502LV-BI7N8-15-6-4K-3840x2160-IPS-Intel-i7-10750H-2-6-GHz-16GB-1TB-SSD-NVIDIA-GeForce-RTX-2060-6G/